activemotif.com
New TET2 Research Describes a New Chromatin-Regulation Pathway and a Novel Cancer Target
A new vulnerability in TET2-mutant leukemia has emerged. Targeting MBD6 significantly impaired leukemia cell growth and reversed disease-related defects in mouse models, opening the door to novel trea...